This lipid-based transfection reagent is issued from the revolutionary Tee-technology and achieves up to 50-55% transfection efficiency.
Oz Biosciences announces the launch of a specific lipid-based transfection reagent dedicated to Vero cells transfection with up to 50% transfection efficiency.
VeroFect is a powerful reagent dedicated to the transfection of Vero cells.
The complexes formed by DNA and VeroFect reagent have an exceptional capacity in destabilising cell membranes, allowing the delivery of important DNA amounts into cells.
VeroFect was specifically designed to obtain highly efficient and reproducible transfection of Vero cells.
Transfection efficiency exceeds most of others transfection reagents.
VeroFect is a non-toxic gene delivery method.
Consequently the quantity of DNA can be maximised in order to achieve the highest transfection efficiency without toxicity.
Oz Biosciences creates, develops and produces innovative tools based on drug delivery systems for the worldwide scientific community and pharmaceutical industry.
OZ Biosciences focuses on technologies for the delivery of bioactive materials into living organisms.
The mission is to promote and accelerate this exploration by providing the innovative and efficient molecular delivery systems sought by scientists.
The company has established a strong position in the field of molecular delivery systems with several patents that exploit revolutionary molecules and methods.
Located at the Luminy Scientific Park, the heart of important biological research activity in Marseille, in the south of France, many local, national and international partnerships and collaborations with academic and industrial research laboratories have been created and the company has received several prestigious national and international awards.
